3/13
04:05 pm
inab
IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Low
Report
IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
3/3
09:37 am
inab
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases [Yahoo! Finance]
Medium
Report
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases [Yahoo! Finance]
3/3
09:28 am
inab
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
Medium
Report
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
2/26
08:00 am
inab
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
Medium
Report
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
2/24
08:00 am
inab
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Low
Report
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
2/14
11:31 am
inab
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML [Yahoo! Finance]
Medium
Report
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML [Yahoo! Finance]
2/14
09:00 am
inab
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
Medium
Report
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
2/12
08:00 am
inab
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
2/11
06:04 pm
inab
This MIcro Cap Found Mid-Week Success On New Clinical Data [Globe and Mail, The (Toronto, Canada)]
Low
Report
This MIcro Cap Found Mid-Week Success On New Clinical Data [Globe and Mail, The (Toronto, Canada)]
2/11
08:41 am
inab
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients [Yahoo! Finance]
High
Report
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients [Yahoo! Finance]
2/11
08:00 am
inab
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
High
Report
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
1/6
07:00 am
inab
IN8bio to Present at Biotech Showcase 2025 in San Francisco
High
Report
IN8bio to Present at Biotech Showcase 2025 in San Francisco